Specific antibody responses to Qβ‐displayed Plasmodium falciparum‐derived UB05 and MSP3 proteins in mother–neonate couples
- 19 August 2024
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 100 (5) , e13404
Abstract
Malaria blood‐stage parasite is a critical pathogenic stage responsible for serious adverse outcomes in pregnant women and their neonates. Immunoglobulin G (IgG) antibody responses specific to various asexual blood‐stage antigens were well reported in non‐pregnant individuals. However, little is still known during placental malaria. To assess the antibody responses specific to Plasmodium falciparum‐derived MSP3 and UB05 malaria vaccine candidates in mother‐neonate couples, mother's peripheral blood and neonate's cord blood samples were collected at delivery. After malaria diagnostic, plasma levels of IgG and IgG subclass responses specific to UB05, MSP3 and UB05‐MSP3 were determined using ELISA. As outcomes, both mothers and neonates had significantly higher IgG responses to UB05 and UB05‐MSP3 compared to anti‐MSP3 IgG (p < 0.05), irrespective of malaria status. Significant negative correlations were observed between IgG levels specific to the three antigens and parasitaemia (p < 0.01). Anti‐UB05 and anti‐UB05‐MSP3 IgG levels in neonates showed a significant positive correlation with the corresponding mothers' antibodies (rs = 0.25 with p = 0.04; rs = 0.31 with p = 0.01, respectively). UB05MSP3‐specific IgG3 and IgG1 subclass responses were significantly higher than the IgG4 subclass (p < 0.01). The neonates IgG1 and IgG3 levels positively correlated with the corresponding antibody subclasses of mothers. These findings suggest an association between UB05 and UB05‐MSP3‐specific antibody responses and malaria control during pregnancy. Maternal–foetal transfer of MSP3 and UB05‐specific IgG occurs during pregnancy, suggesting the interest in the future malaria vaccination strategies in pregnant women to generate early protective immunity in baby against malaria.Keywords
Funding Information
- European and Developing Countries Clinical Trials Partnership
- The World Academy of Sciences
This publication has 31 references indexed in Scilit:
- Transplacental transfer of total immunoglobulin G and antibodies to Plasmodium falciparum antigens between the 24th week of gestation and termScientific Reports, 2022
- Antibody responses to Plasmodium falciparum and Plasmodium vivax blood-stage and sporozoite antigens in the postpartum periodScientific Reports, 2016
- Differential T‐cell responses to a chimeric Plasmodium falciparum antigen; UB05‐09, correlates with acquired immunity to malariaParasite Immunology, 2016
- Immunization of pregnant women: Future of early infant protectionHuman Vaccines & Immunotherapeutics, 2015
- Role of some biomarkers in placental malaria in women living in Yaoundé, CameroonActa Tropica, 2015
- Protection against Malaria by MSP3 Candidate VaccineNew England Journal of Medicine, 2011
- Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidateVaccine, 2010
- FcRn: the neonatal Fc receptor comes of ageNature Reviews Immunology, 2007
- Epidemiology and burden of malaria in pregnancyThe Lancet Infectious Diseases, 2007
- Plasmodium falciparum Inhibitory Capacities of Paired Maternal-cord Sera from South-west Province, CameroonJournal of Tropical Pediatrics, 2005